FDA inspection
Zhejiang Huahai Pharmaceutical: FDA inspection ending Nov 20, 2024
FDA inspection 1255905 · Voluntary Action Indicated (VAI) · Linhai
Key facts
| Inspection ID | 1255905 |
|---|---|
| Firm | Zhejiang Huahai Pharmaceutical |
| FEI number | 3003885745 |
| Address | Coastal Industrial Zone, Chuannan No. 1 Branch No. 9, Donghai 5th Avenue |
| City | Linhai |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Nov 20, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data